Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSP Neuro Serum for Chemotherapy-induced Peripheral Neuropathy
NCT05052398Phase 2Recruiting
- Sponsor
- Algenis
- Start
- Jan 2021
- Primary completion
- Jul 2024
- Countries
- 1
01
Overview
A Phase 2 trial of PSP NEURO SERUM in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Algenis. Started Jan 2021; status: recruiting.
02
Drugs
PSP NEURO SERUM
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT05052398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05052398.